Compare REGN & SHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REGN | SHW |
|---|---|---|
| Founded | 1988 | 1866 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | RETAIL: Building Materials |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.8B | 82.4B |
| IPO Year | 1995 | 1994 |
| Metric | REGN | SHW |
|---|---|---|
| Price | $673.98 | $326.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 10 |
| Target Price | ★ $830.16 | $375.30 |
| AVG Volume (30 Days) | 724.5K | ★ 1.9M |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | 0.55% | ★ 1.01% |
| EPS Growth | ★ 8.19 | N/A |
| EPS | ★ 6.75 | 2.15 |
| Revenue | $5,872,227,000.00 | ★ $17,900,800,000.00 |
| Revenue This Year | $12.45 | $5.34 |
| Revenue Next Year | $10.13 | $4.64 |
| P/E Ratio | ★ $97.19 | $147.68 |
| Revenue Growth | ★ 20.82 | 2.09 |
| 52 Week Low | $541.00 | $289.86 |
| 52 Week High | $821.11 | $379.65 |
| Indicator | REGN | SHW |
|---|---|---|
| Relative Strength Index (RSI) | 55.08 | 50.22 |
| Support Level | $648.66 | $322.47 |
| Resistance Level | $670.96 | $338.43 |
| Average True Range (ATR) | 14.60 | 8.11 |
| MACD | -0.72 | -2.42 |
| Stochastic Oscillator | 51.44 | 59.79 |
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.
Sherwin-Williams is the largest global manufacturer of paints and coatings. The company focuses on the development, manufacturing, and distribution of paint, coatings, and related products to customers ranging from professional painters and contractors to industrial manufacturers to do-it-yourself consumers. Sherwin organizes its operations into three primary segments: the paint stores group is the largest segment and includes the company's network of over 4,800 company-owned stores; the consumer brands group sells branded architectural paints through big-box retailers such as Lowe's, and the performance coatings group provides specialized coatings for industrial applications, such as automotive refinishing, packaging, and industrial wood.